Vesalic
Pre-clinicalVesalic is developing a novel therapy to neutralize exosome-borne toxins and potentially slow or halt the progression of ALS.
Founded
2012
Focus
OncologyAI / Machine Learning
About
Vesalic is developing a novel therapy to neutralize exosome-borne toxins and potentially slow or halt the progression of ALS.
Company Info
TypePrivate
Founded2012
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile